Data | Reference | |
---|---|---|
Lipid profile | ||
Cholesterol, Total | 179 | < 200 mg/dL |
Triglycerides | 253 | < 200 mg/dL |
LDL | 114 | < 130 mg/dL |
Lipoprotein a | 133 | < 75 nmol/L |
Hypercoagulation | ||
Beta-2-glycoprotein Antibody, IgG | < 10.0 | < 20.1 CU |
Beta-2-glycoprotein Antibody, IgM | < 5.0 | < 20.1 CU |
Protein C, Activity | 99 | 76–146% |
Anti-Cardiolipin Antibody, IgG | 15.8 | < 20.1 CU |
Anti-Cardiolipin Antibody, IgM | < 10.0 | < 20.1 CU |
Lupus Anticoagulant by HEXA | Neg | Neg |
RVVT Seconds | 30.9 | 29.0–44.0 s |
CSF studies | ||
WBC | 1 | < 6 x10E6/L |
RBC | 44 | 0 x10E6/L |
Glucose | 76 | 40–70 mg/dL |
Protein | 13 | 15–50 mg/dL |
IgG Index | 0.6 | 0.3–0.6 Ratio |
Serum glucose | 164 | < 200 |
Rapid HSV-1 PCR | Neg | Neg |
Rapid HSV-2 PCR | Neg | Neg |
VZV PCR | Neg | Neg |
VZV IgM | 0.03 | < 0.9 |
Autoimmune/Endocrine | ||
Hemoglobin A1c | 6.4 | 4.3–5.6% |
TSH | 0.64 | 0.45–4.12 mlU/L |
Free T4 | 13 | 10–18 pmol/L |
CRP | 5.4 - > 36.9 | < 6.3 |
ESR | > 100 | 0–15 mm/h |
Anti-Nuclear Antibodies | < 40 | < 40 |
Anti Proteinase 3 Ab | < 10.0 | < 20.0 CU |
Anti Myeloperoxidase | < 10.0 | < 20.0 CU |
GAD-65 Autoantibodies | < 1.0 | < 1.0 U/mL |
Insulin Autoantibody | < 0.4 | < 0.4 U/mL |
Islet Cell Antigen 512 Antibody | < 0.8 | < 0.8 U/mL |
Rheumatoid Factor, serum | < 40 | < 40 IU/mL |
Complement C3, serum | 101 | 71–159 mg/dL |
Complement C4, serum | 26.4 | 13–30 mg/dL |
Cryoglobulin | < 0.12 | < 0.12 g/L |
Heterophile Agglutination | Neg | Neg |
Infectious | ||
Hepatitis B sAb | < 5 | mIU/mL |
Hepatitis B cAb | Neg | Neg |
Hepatitis B sAg | Neg | Neg |
Hepatitis C Antibody | Neg | Neg |
HIV Ag/Ab | Neg | Neg |